Anogenital cancers testing in Rufina

Find health labs to test for Anogenital cancers in Rufina and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Synlab

Via Fratelli Cervi, 19, 50065 Pontassieve FI, Italia

4.3 km

Unverified

See Details

Pap Smear by Casa della Salute

Via San Benedetto, 20, 50066 Reggello FI, Italia

10.2 km

Unverified

See Details

Pap Smear by Synlab

Via Antonio Gramsci, 8, 50014 Fiesole FI, Italia

9.8 km

Unverified

See Details

Pap Smear by Synlab

Piazza Dante Alighieri, 63, 50032 Borgo San Lorenzo FI, Italia

10.2 km

Unverified

See Details

Pap Smear by Synlab

Viale Edmondo De Amicis, 87, 50137 Firenze FI, Italia

12.2 km

Unverified

See Details

Pap Smear by Synlab

Via di Ripoli, 164, 50126 Firenze FI, Italia

12.2 km

Unverified

See Details

Pap Smear by Synlab

Via Erbosa, 66, 50126 Firenze FI, Italia

12.2 km

Unverified

See Details

Pap Test by Crabion S.R.L.

Piazza Giuseppe Mazzini, 52017 Pratovecchio Stia AR, Italia

33.3 km

Unverified

See Details

Pap Smear by Synlab

Via Franco Sacchetti, 12, 50133 Firenze FI, Italia

12.2 km

Unverified

See Details

Pap Smear by Synlab

Viale dei Mille, 90, 50131 Firenze FI, Italia

12.2 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.